tiprankstipranks
Carisma Therapeutics (CARM)
NASDAQ:CARM
US Market

Carisma Therapeutics (CARM) Income Statement

Compare
1,570 Followers

Carisma Therapeutics Income Statement

Last quarter (Q3 2024), Carisma Therapeutics's total revenue was $3.38M, a decrease of -11.55% from the same quarter last year. In Q3, Carisma Therapeutics's net income was $-12.70M. See Carisma Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 14.92M$ 9.83M$ 26.54M$ 11.24M$ 0.00
Gross Profit
$ -59.21M$ 3.74M$ 26.46M$ 11.24M$ -219.00K
Operating Expenses
$ 103.65M$ 59.91M$ 40.79M$ 28.38M$ 36.65M
Depreciation and Amortization
$ 2.84M$ 6.09M$ 85.00K$ 122.00K$ 219.00K
EBITDA
$ -85.89M$ -51.99M$ -40.11M$ -27.93M$ -107.28M
Operating Income
$ -88.73M$ -56.16M$ -40.79M$ -28.38M$ -36.87M
Other Income/Expenses
$ 1.85M$ -5.06M$ 10.00K$ 29.00K$ -70.63M
Pretax Income
$ -86.88M$ -61.23M$ -40.78M$ -28.35M$ -107.50M
Net Income
$ -86.88M$ -61.23M$ -40.77M$ -28.32M$ -107.50M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.59$ -575.42$ -4.47$ -4.79$ -23.64
Diluted EPS
$ -2.59$ -575.42$ -4.47$ -4.79$ -23.64
Weighted Average Shares Outstanding
33.52M 106.40K 9.12M 5.91M 4.55M
Weighted Average Shares Outstanding (Diluted)
33.52M 106.40K 9.12M 5.91M 4.55M
Currency in USD

Carisma Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis